The Early Development of the Vaccinia–Rabies Recombinant Vaccine Raboral®
The recombinant vaccinia–rabies vaccine, now known as Raboral®, has been widely used in Europe and North America to control/eliminate rabies in the principal wildlife vectors, and thus prevent human transmission. The origins of this vaccine are sometimes forgotten, although the formulation has not c...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2021
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/76468 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: The Early Development of the Vaccinia–Rabies Recombinant Vaccine Raboral®
- Rabies Virus Infection in Livestock
- Rabies: Incurable Biological Threat
- Human Rabies Epidemiology and Diagnosis
- Expression and Characterization of Bovine Milk Antimicrobial Proteins Lactoperoxidase and Lactoferrin by Vaccinia Virus
- Introductory Chapter: Rabies in the 21st Century
- Recombination and Point Mutations in Type G Rotavirus Strains: The Challenges of Vaccine Development